Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study

被引:25
|
作者
Choi, Hayoung [2 ,3 ]
Lee, Hyun [1 ]
Ryu, Jiin [4 ]
Chung, Sung Jun [1 ]
Park, Dong Won [1 ]
Sohn, Jang Won [1 ]
Yoon, Ho Joo [1 ]
Kim, Sang-Heon [1 ]
机构
[1] Hanyang Univ, Dept Internal Med, Coll Med, 222 Wangsimni Ro, Seoul 04763, South Korea
[2] Hallym Univ, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Kangnam Sacred Heart Hosp, Seoul, South Korea
[3] Hallym Univ, Lung Res Inst, Coll Med, Chunchon, South Korea
[4] Hanyang Univ, Med Res Collaborating Ctr, Biostat Consulting & Res Lab, Seoul, South Korea
关键词
asthma; bronchiectasis; corticosteroid; epidemiology; mortality; HEALTH-CARE;
D O I
10.1177/1753466620963030
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Long-term corticosteroid (CS) use is associated with increased mortality in patients with asthma, and comorbid bronchiectasis is also associated with frequent asthma exacerbation and increased healthcare use. However, there is limited information on whether bronchiectasis further increases mortality in patients with CS-dependent asthma. This study examined the impact of bronchiectasis on mortality in patients with CS-dependent asthma. Methods: A retrospective cohort of patients with CS-dependent asthma > 18 years old was established using records from the Korean National Health Insurance Service database from 2005 to 2015. Patients with CS-dependent asthma with and without bronchiectasis were matched by age, sex, type of insurance, and Charlson comorbidity index. We evaluated the hazard ratio (HR) for all-cause mortality in patients with bronchiectasis compared with those without bronchiectasis. Results: The study cohort included 754 patients with CS-dependent asthma with bronchiectasis and 3016 patients with CS-dependent asthma without bronchiectasis. Patients with CS-dependent asthma with bronchiectasis had a higher all-cause mortality than those without bronchiectasis (8429/100,000versus6962/100,000 person-years, p < 0.001). The adjusted HR for mortality in patients with CS-dependent asthma with bronchiectasis relative to those without bronchiectasis was 1.33 (95% confidence interval, 1.18-1.50), and the association was primarily significant for respiratory diseases (subdistribution HR = 1.65, 95% confidence interval, 1.42-1.92). Conclusions: Bronchiectasis further increases all-cause mortality in patients with CS-dependent asthma, a trend that was especially associated with respiratory diseases including chronic obstructive pulmonary disease. Strategies to improve treatment outcomes in patients with CS-dependent asthma with bronchiectasis are urgently needed to improve long-term survival. The reviews of this paper are available via the supplemental material section.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] COST EFFECTIVENESS OF BENRALIZUMAB FOR SEVERE, UNCONTROLLED ORAL CORTICOSTEROID-DEPENDENT ASTHMA IN SWEDEDN
    Andersson, M.
    Janson, C.
    Kristensen, T.
    Szende, A.
    Golam, S.
    VALUE IN HEALTH, 2019, 22 : S876 - S877
  • [22] Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid-dependent asthma in Sweden
    Andersson, Maria
    Janson, Christer
    Kristensen, Thomas
    Szende, Agota
    Golam, Sarowar
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (08) : 877 - 884
  • [23] Climate Change to Blame in Severe Oral Corticosteroid-Dependent Asthma? A Case Report
    Huang, Chunrong
    Shi, Guochao
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 5
  • [24] METHOTREXATE FOR THE TREATMENT OF CHRONIC CORTICOSTEROID-DEPENDENT ASTHMA
    REID, DJ
    SEGARS, LW
    CLINICAL PHARMACY, 1993, 12 (10): : 762 - 767
  • [25] Hypogammaglobulinemia in a patient with corticosteroid-dependent asthma.
    Rao, VU
    Apter, AJ
    CLINICAL IMMUNOLOGY, 2005, 116 (03) : 300 - 300
  • [26] KAPOSIS SARCOMA IN THE COURSE OF CORTICOSTEROID-DEPENDENT ASTHMA
    GUILLOT, B
    AUBAS, P
    MICHEL, FB
    SEMAINE DES HOPITAUX, 1989, 65 (15): : 939 - 940
  • [27] METHOTREXATE IN THE TREATMENT OF A CHILD WITH CORTICOSTEROID-DEPENDENT ASTHMA
    STEMPEL, DA
    MULLARKEY, MF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 255 - 255
  • [28] A placebo-controlled multicenter study of auranofin in the treatment of Patients with corticosteroid-dependent asthma
    Bernstein, IL
    Bernstein, DI
    Dubb, JW
    Faiferman, I
    Wallin, B
    Bronsky, E
    Spector, SL
    Nathan, RA
    Nelson, HS
    Bardana, EJ
    Blumenthal, MN
    Bone, RC
    Briggs, DD
    Busse, WW
    Campbell, SC
    Condemi, JJ
    Crain, MR
    Grossman, J
    Handley, GJ
    Kemp, JP
    Klaustermeyer, WB
    Ledford, DK
    Lockey, RF
    Lopez, M
    McNeil, DL
    Metzger, WJ
    Montanaro, A
    Pinnas, JL
    Schoenwetter, WF
    Townley, RG
    Valentine, MD
    VanArsdel, PP
    Vari, AJ
    Weisberg, SC
    Zeitz, HJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (02) : 317 - 324
  • [29] DUPILUMAB REDUCES SEVERE EXACERBATIONS IN PATIENTS WITH ORAL CORTICOSTEROID-DEPENDENT SEVERE ASTHMA WITH AND WITHOUT EARLY IMPROVEMENTS IN LUNG FUNCTION
    Hanania, Nicola
    Castro, Mario
    Mirapeix, Christian
    Bateman, Eric
    Rice, Megan
    Djandji, Michel
    Ballard, Mark
    Rowe, Paul
    Deniz, Yamo
    Teper, Ariel
    CHEST, 2019, 156 (04) : 929A - 932A
  • [30] COMORBIDITIES IN ELDERLY PATIENTS WITH ORAL CORTICOSTEROID-DEPENDENT ASTHMA IN SOUTH KOREA
    Pyun, D.
    Bae, E. J.
    Kim, M. K. M.
    Park, S.
    Suh, H. S.
    VALUE IN HEALTH, 2023, 26 (06) : S170 - S170